Please assess the completion status of the following clinical trial:

Trial Title: Efficacy of Biphasic Insulin Aspart 30 in Type 2 Diabetics Failing on OADs

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Type 2 diabetes mellitus for at least 12 months~* HbA1c: 7.5-10.0%~* An antidiabetic regimen that has been stable for at least 3 months~* Able and willing to perform SMBG testing as per protocol~Exclusion Criteria:~* Use of any insulin preparations other than NPH or glargine within the past 6 months~* Pregnancy, breastfeeding, intention to become pregnant within the next 12 months, or judged to be using inadequate contraceptive measures (adequate contraceptive measures includes: sterilization, intrauterine devices, oral contraceptives, or consistent use of barrier methods)~* Known or suspected allergy to trial product or agents related to trial product

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- A (Type: EXPERIMENTAL): None

Based on this trial design, predict the completion outcome and termination type (if applicable).